Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the company said Monday. The device is designed for people with symptomatic ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Edwards Lifesciences Corporation, leading global structural heart innovation company, announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment ...

April 14, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter ...

"Edwards secures CE mark for transfemoral mitral valve implant" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

One-year follow-up data suggest that a novel transcatheter tricuspid valve replacement (TTVR) device may provide another potential ... Sustained TR Reductions The single-arm study included 126 ...